85 related articles for article (PubMed ID: 8039940)
21. Biocompatibility of three different membrane oxygenators: effects on complement, neutrophil and monocyte activation.
de Vroege R; Rutten PM; Kalkman C; Out TA; Jansen PG; Eijsman L; de Mol BJ; Wildevuur CR
Perfusion; 1997 Nov; 12(6):369-75. PubMed ID: 9413849
[TBL] [Abstract][Full Text] [Related]
22. [A study on complement activation in cardiopulmonary bypass--experimental and clinical evaluations].
Yamasaki M
Nihon Kyobu Geka Gakkai Zasshi; 1989 Feb; 37(2):234-41. PubMed ID: 2788676
[TBL] [Abstract][Full Text] [Related]
23. Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass.
Gu YJ; van Oeveren W; Boonstra PW; de Haan J; Wildevuur CR
Ann Thorac Surg; 1992 May; 53(5):839-43. PubMed ID: 1315132
[TBL] [Abstract][Full Text] [Related]
24. Reduced complement activation during cardiopulmonary bypass does not affect the postoperative acute phase response.
van den Goor J; Nieuwland R; van den Brink A; van Oeveren W; Rutten P; Tijssen J; Eijsman L
Eur J Cardiothorac Surg; 2004 Nov; 26(5):926-31. PubMed ID: 15519184
[TBL] [Abstract][Full Text] [Related]
25. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
[TBL] [Abstract][Full Text] [Related]
26. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins.
Chenoweth DE; Cooper SW; Hugli TE; Stewart RW; Blackstone EH; Kirklin JW
N Engl J Med; 1981 Feb; 304(9):497-503. PubMed ID: 7453783
[TBL] [Abstract][Full Text] [Related]
27. The calcium channel blocker nifedipine fails to inhibit leucocyte elastase release during cardiopulmonary bypass.
Massaut J; Hennebert N; Tasiaux N; Demanet H
Acta Anaesthesiol Scand; 1993 Jan; 37(1):82-4. PubMed ID: 8424302
[TBL] [Abstract][Full Text] [Related]
28. Pulsatile compared with nonpulsatile perfusion using a centrifugal pump for cardiopulmonary bypass during coronary artery bypass grafting. Effects on systemic haemodynamics, oxygenation, and inflammatory response parameters.
Driessen JJ; Dhaese H; Fransen G; Verrelst P; Rondelez L; Gevaert L; van Becelaere M; Schelstraete E
Perfusion; 1995; 10(1):3-12. PubMed ID: 7795311
[TBL] [Abstract][Full Text] [Related]
29. Cardiopulmonary bypass primes polymorphonuclear leukocytes.
Schwartz JD; Shamamian P; Schwartz DS; Grossi EA; Jacobs CE; Steiner F; Minneci PC; Baumann FG; Colvin SB; Galloway AC
J Surg Res; 1998 Mar; 75(2):177-82. PubMed ID: 9655092
[TBL] [Abstract][Full Text] [Related]
30. Myeloperoxidase and elastase as markers of leukocyte activation during cardiopulmonary bypass in humans.
Faymonville ME; Pincemail J; Duchateau J; Paulus JM; Adam A; Deby-Dupont G; Deby C; Albert A; Larbuisson R; Limet R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):309-17. PubMed ID: 1650868
[TBL] [Abstract][Full Text] [Related]
31. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
[TBL] [Abstract][Full Text] [Related]
32. Source of fibrin/fibrinogen degradation products in the CSF after subarachnoid hemorrhage.
Vermeulen M; van Vliet HH; Lindsay KW; Hijdra A; van Gijn J
J Neurosurg; 1985 Oct; 63(4):573-7. PubMed ID: 3897478
[TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
34. Effect of C1-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates.
Tassani P; Kunkel R; Richter JA; Oechsler H; Lorenz HP; Braun SL; Eising GP; Haas F; Paek SU; Bauernschmitt R; Jochum M; Lange R
J Cardiothorac Vasc Anesth; 2001 Aug; 15(4):469-73. PubMed ID: 11505352
[TBL] [Abstract][Full Text] [Related]
35. Blood--artificial surface interactions during cardiopulmonary bypass. A comparative study of four oxygenators.
Benedetti M; De Caterina R; Bionda A; Gardinali M; Cicardi M; Maffei S; Gazzetti P; Pistolesi P; Vernazza F; Michelassi C
Int J Artif Organs; 1990 Aug; 13(8):488-97. PubMed ID: 2146229
[TBL] [Abstract][Full Text] [Related]
36. Leukocyte and platelet depletion with a blood cell separator: effects on lung injury after cardiac surgery with cardiopulmonary bypass.
Morioka K; Muraoka R; Chiba Y; Ihaya A; Kimura T; Noguti H; Uesaka T
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):45-54. PubMed ID: 8551788
[TBL] [Abstract][Full Text] [Related]
37. Trillium biopassive surface: a new biocompatible treatment for extracorporeal circulation circuits.
Cazzaniga A; Ranucci M; Isgrò G; Soro G; De Benedetti D; Corradi R; Gardinali M
Int J Artif Organs; 2000 May; 23(5):319-24. PubMed ID: 10872850
[TBL] [Abstract][Full Text] [Related]
38. Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.
Dietrich W; Mössinger H; Spannagl M; Jochum M; Wendt P; Barankay A; Meisner H; Richter JA
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):712-20. PubMed ID: 7682267
[TBL] [Abstract][Full Text] [Related]
39. Autotransfusion management during and after cardiopulmonary bypass alters fibrin degradation and transfusion requirements.
Wiefferink A; Weerwind PW; van Heerde W; Teerenstra S; Noyez L; de Pauw BE; Brouwer RM
J Extra Corpor Technol; 2007 Jun; 39(2):66-70. PubMed ID: 17672185
[TBL] [Abstract][Full Text] [Related]
40. A closed perfusion system with heparin coating and centrifugal pump improves cardiopulmonary bypass biocompatibility in elderly patients.
Lindholm L; Westerberg M; Bengtsson A; Ekroth R; Jensen E; Jeppsson A
Ann Thorac Surg; 2004 Dec; 78(6):2131-8; discussion 2138. PubMed ID: 15561050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
